Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Flavio Solca is active.

Publication


Featured researches published by Flavio Solca.


Journal of Receptors and Signal Transduction | 1991

Biologically active monoiodinated α-MSH derivatives for receptor binding studies using human melanoma cells

Alex N. Eberle; Vreni Jäggin Verin; Flavio Solca; Walter Siegrist; Caroline Küenlin; Claudia Bagutti; Sibylla Stutz; J. Girard

Three different monoiodinated radioligands of alpha-MSH (alpha-melanocyte-stimulating hormone) were compared in a binding assay with human D10 melanoma cells: [Tyr(125I)2]-alpha-MSH, [Tyr(125I)2,NIe4]-alpha-MSH, and [Tyr(125I)2,NIe4,D-Phe7]-alpha-MSH. They were prepared either by the classical chloramine T method or by the Enzymobead method. A simple and rapid purification scheme was developed consisting of a primary separation on reversed-phase C18 silica cartridges immediately after the iodination, followed by HPLC purification before each binding experiment. Biological testing of the three radioligands showed that they all retained high melanotropic activity in the B16 melanin assay and the Anolis melanophore assay. However, in human D10 melanoma cells, [Tyr(125I)2,NIe4]-alpha-MSH led to a high degree of non-specific binding to the cells which could not be displaced by excess alpha-MSH and only partially by [NIe4]-alpha-MSH. The [Tyr(125I)2,NIe4,D-Phe7]-alpha-MSH tracer gave similar results but with a much lower proportion of non-specific binding. On the other hand, [Tyr(125I)2]-alpha-MSH proved to be an excellent radioligand whose non-specific binding to the D10 cells was not higher than 20% of the total binding.


FEBS Letters | 1993

B16-G4F mouse melanoma cells: An MSH receptor-deficient cell clone

Flavio Solca; Johanna Chluba-de Tapia; Kunio Iwata; Alex N. Eberle

The two mouse melanoma cell lines B16‐F1 and B16‐G4F retain their melanogenic capacity when cultured in vitro. Melanotropic peptides such as α‐melanocyte‐stimulating hormone (α‐MSH) induce formation and release of melanin pigment in B16‐F1 cells. In contrast, B16‐G4F cells do not respond to α‐MSH. Using receptor‐binding analysis and photoaffinity crosslinking we demonstrate that the lack of response of B16‐G4F cells to α‐MSH is due to the absence of functional MSH receptors from the cell surface. Northern blot analysis of receptor mRNA revealed that MSH receptor mRNA is not expressed in B16‐G4F cells. These cells represent a new tool for the study of signal pathways related to the control of melanogenesis in melanoma cells.


Journal of Receptors and Signal Transduction | 1991

Heterogeneity of the MSH Receptor Among B16 Murine Melanoma Subclones

Flavio Solca; Yoram Salomon; Alex N. Eberle

The heterogeneity of melanotropin receptors on B16 sublines was tested by using photoaffinity crosslinking techniques and the superpotent alpha-MSH derivative [Nle4, D-Phe7, 1-(2-nitro-4-azido-phenylsulfenyl)-Trp9]-alpha- MSH (NAPS-MSH). Specific crosslinking of this compound to B16-F1, B16-F10, B16-M2R or B16-W4 cells revealed three different subtypes of MSH receptor based on SDS-PAGE analysis. Binding of monoiodinated alpha-MSH to these different subclones is saturable and characteristic for a single class of complexes (0.9 nM less than KD less than 1.6 nM). In this article the nature of the different MSH receptor subtypes as well as their possible correlation to the melanogenic potential of a particular cell line is discussed.


Archive | 1989

Photoaffinity Labelling of Receptors for Melanocyte-Stimulating Hormone

Alex N. Eberle; Flavio Solca; W. Siegrist; Teresa Scimonelli; J. Girard; P. N. E. de Graan

The photoaffinity labelling technique was applied to the study of receptors for α-melanocyte-stimulating hormone (α-MSH; α-melanotropin) on mouse and human melanoma cells as well as on Xenopus and Anolis melanophores. Twenty different α-MSH analogues containing one, two or three photolabels were synthesized and tested as photoprobes. A highly potent nitrene-generating azidophenyl compound, monoiodinated [4-Nle, 7- D-Phe, 9-Trp(Naps)]-α-MSH, was most suitable for the biochemical analysis of MSH receptors on melanoma cells whereas the physiological effects following photolabelling of intact cultured cells were best studied by using carbene-generating phenyldiazirine α-MSH analogues. Covalent linkage of α-MSH to its receptor on both melanoma cells and melanophores produced a long-lasting receptor stimulation. This irreversible agonism served as a new tool for the analysis of signal transduction mechanisms. The biochemical characterization of the covalent α-MSH-receptor complex of melanoma cells revealed a 45 kDa membrane glycoprotein, probably containing a relatively high content of sialic acid, thus explaining the acidic pi (4.7) of this receptor.


Cancer Research | 1989

Characterization of Receptors for α-Melanocyte-stimulating Hormone on Human Melanoma Cells

Walter Siegrist; Flavio Solca; Sibylla Stutz; Laura Giuffrè; Stefan Carrel; J. Girard; Alex N. Eberle


Archive | 2006

Treatment of cancer with indole derivatives

Wolfgang Sommergruber; Norbert Kraut; Norbert Schweifer; Wolfgang J. Rettig; Frank Hilberg; Flavio Solca; Martin Steegmaier


Progress in Histochemistry and Cytochemistry | 1992

3.5 MSH receptors on mouse and human melanoma cells: receptor identification, analysis and quantification

Walter Siegrist; Claudia Bagutti; Flavio Solca; J. Girard; Alex N. Eberle


Pharmacology & Therapeutics | 1989

Photoaffinity labeling of melanocyte-stimulating hormone receptors

Alex N. Eberle; Pierre N. E. De Graan; Teresa Scimonelli; Flavio Solca


Archive | 1991

Peptides containing multiple photolabels for studies of hormone-receptor interactions

Alex N. Eberle; Roma Drozdz; Flavio Solca; J. Girard


Cancer Research | 2018

Abstract 1852: Combination of the CDK4/6 inhibitor abemaciclib with xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, results in synergistic antineoplastic effects in human breast cancer cell lines

Ulrike Weyer-Czernilofsky; Rosa Baumgartinger; Susanne Schmittner; Xueqian Gong; Sean Buchanan; Richard P. Beckmann; Carlos Marugán; Raquel Torres; Karsten Boehnke; María José Lallena; Flavio Solca; Norbert Kraut; Thomas Bogenrieder

Collaboration


Dive into the Flavio Solca's collaboration.

Top Co-Authors

Avatar

Alex N. Eberle

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

J. Girard

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Walter Siegrist

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge